via Email the first business day after the date sent (without any undeliverable notification being returned), (ii)
via Email. To: BRAINGRID LIMITED Attention to: Xxxxxxx Xxxxxxxx E-mail addresses: xxxxxxx@xxxxxxxxx.xx Dear Sir, We refer to the subscription agreement entered into between European High Growth Opportunities Securitization Fund and Braingrid Limited dated June 11, 2019 (the “Subscription Agreement”). All terms written with a capital initial letter shall have the definition ascribed to them in the Subscription Agreement. In accordance with Section 2.2(d) of the Subscription Agreement, the undersigned hereby exercises its right to accelerate the issuance of $[●] principal amount of Debentures and accompanying Facility Warrants, and instructs the Corporation to accelerate the applicable Issuance Date in respect of the [Second Closing, Third Closing, Fourth Closing, Fifth Closing, Sixth Closing, Seventh Closing, Eighth Closing, Ninth Closing, Tenth Closing, Eleventh Closing, Twelfth Closing, Thirteenth Closing, Fourteenth Closing, Fifteenth Closing, Sixteenth Closing, Seventeenth Closing, or Eighteenth Closing]. On the _ day of , 201__. Sincerely, EUROPEAN HIGH GROWTH OPPORTUNITIES SECURITIZATION FUND, REPRESENTED BY EUROPEAN HIGH GROWTH OPPORTUNITIES XXXXX XX Per: Name: Title: VIA EMAIL BRAINGRID LIMITED Attention to: Xxxxxxx Xxxxxxxx E-mail addresses: xxxxxxx@xxxxxxxxx.xx Reference is made to the subscription agreement dated June 11, 2019 (the “Subscription Agreement”) between the Investor and the Corporation, and a Conversion Notice delivered pursuant to the Subscription Agreement on [], 2019 (the “Reference Notice”). All terms used herein but otherwise undefined shall have the definition ascribed to them in the Subscription Agreement. For the purpose of this notice, the following terms shall have the following meanings:
via Email. The undersigned hereby irrevocably elects to convert a portion of the outstanding and unpaid Conversion Amount of Note No. EGOX-[1][2] into Ordinary Shares of NEXT.E.GO N.V., according to the conditions stated therein, as of the Conversion Date written below. Conversion Date: Principal Amount to be Converted: Accrued Interest to be Converted: Total Conversion Amount to be converted: Fixed Price: Variable Price: Applicable Conversion Price: Number of Ordinary Shares to be issued: Please issue the Ordinary Shares in the following name and deliver them to the following account: Issue to: Broker DTC Participant Code: Account Number: Authorized Signature: Name: Title:
via Email. Xx. Xxxx Xxxxxx 0000 Xxxxxxxxxx Xx. X.X. Xxxxxxxx, XX 00000 Email: xxxxxxx@0000xxxxxxxx.xxx Re: Letter Agreement Regarding the Assignment, Assumption
via Email. The undersigned hereby irrevocably elects to convert a portion of the outstanding and unpaid Conversion Amount of Debenture No. PIK-[1][2][3] into shares of Common Stock of KIDPIK CORP., according to the conditions stated therein, as of the Conversion Date written below. Conversion Date: Principal Amount to be Converted: Accrued Interest to be Converted: Total Conversion Amount to be converted: Fixed Price: Market Price: Applicable Conversion Price: Number of shares of Common Stock to be issued: Please issue the shares of Common Stock in the following name and deliver them to the following account: Issue to: Broker DTC Participant Code: Account Number: Authorized Signature: Name: Title: EXHIBIT B FORM OF IRREVOCABLE TRANSFER AGENT INSTRUCTIONS COMPANY LETTERHEAD [______], 2024 Cleartrust, LLC 10000 Xxxxxx Xxxxxxx Xxxxx Suite 210 Lutz, FL 33558 Ladies and Gentlemen: KIDPIK CORP., a Delaware corporation (the “Company”) and [________]. (the “Investor”) have entered into a Securities Purchase Agreement dated as of _____________, 2024 (the “Agreement”), providing for the issuance of Convertible Debentures in the aggregate principal amount of up to $2,000,000 (the “Debentures”) convertible into shares of common stock, par value $0.001 per share, of the Company (“Common Stock”). A copy of the form of Debentures is attached hereto. You should familiarize yourself with your issuance and delivery obligations, as Transfer Agent, contained therein. The shares to be issued are to be registered in the names of the registered holder of the securities submitted for conversion. You are hereby irrevocably authorized and instructed to reserve a sufficient number of shares of Common Stock of the Company for issuance upon full conversion of the Debentures in accordance with the terms thereof. The amount of Common Stock so reserved shall initially be ________________ shares, as may be increased by the Company in accordance with the Agreement. The ability to convert the Debentures in a timely manner is a material obligation of the Company pursuant to such securities. Your firm is hereby irrevocably authorized and instructed to issue shares of Common Stock of the Company (without any restrictive legend) to the Investors without any further action or confirmation by the Company: (A) upon your receipt from any Investor of: (i) a notice of conversion (“Conversion Notice”) executed by the Investor; and (ii) an opinion of counsel of the Company or the Investor, in form, substance and ...
via Email. Dear: Xxxxxx It gives me great pleasure on behalf of Responsys, Inc. (“The Company”) to offer you employment as VP General Counsel and Secretary on the following terms:
via Email. The undersigned hereby irrevocably elects to convert a portion of the outstanding and unpaid Conversion Amount of Debenture No. NioCorp-[_] into Common Shares of NioCorp Developments Ltd., according to the conditions stated therein, as of the Conversion Date written below. Conversion Date: Principal Amount to be Converted: Accrued Interest to be Converted: Total Conversion Amount to be converted: Conversion Price: Number of shares of Common Shares to be issued: Please issue the shares of Common Shares in the following name and deliver them to the following account: Issue to: Broker DTC Participant Code: Account Number: Authorized Signature: Name: Title:
via Email. Dear Bxxxx: This letter sets forth the substance of the separation agreement (the “Agreement”) that Eagle Pharmaceuticals, Inc. (the “Company”) is offering to you to aid in your employment transition.
via Email. Xx. Xxxxxx Xx 00 Xxxxxxx Xx. New Providence, NJ 07974 Re: Offer of Employment Dear Ruying: The specifics of your offer of employment with Matinas BioPharma Holdings, Inc. (hereinafter referred to as “Matinas” or the “Company”) are outlined below:
via Email. Re: Offer of Employment Dear Hans: This employment letter agreement (the “Agreement”) is entered into between Xxxx Xxxxxxx (“you”) and Xxxxxx Pharma, Inc. (the “Company” or “we”) and will become effective as of the effective date of the Company’s registration statement relating to the Company’s initial public offering (the “Effective Date”). The below sets forth the terms and conditions of your employment with the Company commencing as of the Effective Date.
